Surface Oncology



Surface Oncology is developing next generation immunotherapies that target the immune-suppressive tumor microenvironment to attack cancer.

Jessica Fees
Henry Rath
Chief Business Officer
Vito Palombella
Chief Scientific Officer
Alison O’neill
Chief Medical Officer
Liisa I. Nogelo
Chief Legal Officer
Lisa Mcgrath
SVP, Human Resources
Alison O’neill
SVP, Clinical Development
Benjamin Lee
VP, Translational Science

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.